Results 171 to 180 of about 114,525,696 (300)

In situ monitoring of C60 hydrogenation

, 2011
Kinetics and pathways of C60 reaction with hydrogen gas were studied in a broad temperature interval and over extended periods of time. Specifically, hydrogenation was monitored in situ at high temperature and high hydrogen pressure conditions using gravimetric method. The shape of gravimetric curve was found to depend on hydrogena tion temperature: at
Luzan, S.M., Tsybin, Y.O., Talzyin, A.V.
openaire   +1 more source

In-Situ Monitoring the Magnetotransport Signature of Topological Transitions in a Chiral Magnet. [PDF]

Small Methods
Thomas A, Pohl D, Tahn A, Schlörb H, Schneider S, Kriegner D, Beckert S, Vir P, Winter M, Felser C, Rellinghaus B.   +10 more
europepmc   +1 more source

Overcoming Photodynamic Therapy Resistance: GSH‐Responsive AIE Photosensitizer‐Hydroxycamptothecin Nanoliposomes for Extrahepatic Cholangiocarcinoma

Advanced Healthcare Materials, EarlyView.
A GSH‐responsive AIE nanoplatform (TSH NPs) with RGD‐mediated tumor targeting co‐delivers a photosensitizer (TPA) and HCPT for extrahepatic cholangiocarcinoma. The system synergistically enhances PDT and chemotherapy by suppressing HIF‐1α/VEGF‐driven hypoxic adaptation, effectively overcoming PDT resistance.
Yong Qu, Tao Peng, Yating Zhang, Juanmei Cao, Birong Wang, Chuxing Chai, Zhiyuan Gao, Yiting Xu, Yifan Jin, Yuqing Wang, Zhuoxia Li, Xu Liu, Tianqi Zhao, Yufan Chen, Weimin Lv, Di Lu, Changzheng Huang, Dan Ding, Jinxiang Zhang, Min Li   +19 more
wiley   +1 more source

Biphasic Co‐Delivery of Curcumin and 5‐FU using 3D‐Printed Dissolving Microneedles for Skin Cancer Therapy

Advanced Healthcare Materials, EarlyView.
Using pixel‐aware digital light processing, the authors created high‐resolution, dissolvable microneedles from a PEGDA/VP matrix. These microneedles encapsulate curcumin and 5‐fluorouracil and dissolve in the skin, co‐delivering drugs directly to tumours.
Rutuja N. Meshram, Dimitrios A. Lamprou
wiley   +1 more source

In situ monitoring of pharmaceutical crystallisation [PDF]

, 2012
Using confocal Raman spectroscopy/microscopy, we have monitored pharmaceutical crystallisation 'in situ' in three model (well characterised polymorphic systems) Active Pharmaceutical Ingredients (APIs) and one previously unstudied system where polymorphism had not being reported prior to this study: flufenamic acid, a Non Steroidal Non-Inflammatory ...
openaire   +1 more source

Bioelectronics for <i>In Situ</i> Monitoring of Tumor Microenvironment Markers. [PDF]

Nanotheranostics
Mahato K, Patel GK.
europepmc   +1 more source

Making the Case for Organ‐on‐Chip Platforms in Long‐Acting Therapeutics Development

Advanced Healthcare Materials, EarlyView.
LATs release drug from a tissue‐resident depot over weeks to months, improving adherence, but their development is hampered by preclinical models that cannot reproduce the coupled tissue processes, sustained release, local microenvironment change, interstitial transport, immune and foreign‐body responses, and clearance that govern depot performance in ...
Charlie Gowans, Abdulwahhab Khedr, Panagiotis G. Georgiou, Nehir Arik, Ozlem Sen, Steve P. Rannard, Tom O. McDonald, Christos Tapeinos   +7 more
wiley   +1 more source

In-situ monitoring of microbial circuitry [PDF]

Research Outreach, 2019
openaire   +1 more source

Mechanistic Identification of Oxygen Species in the Degradation of CsPbBr₃ Quantum Dot Films Through Real-Time In Situ Monitoring. [PDF]

Materials (Basel)
Lin Z, Song J, Wu H, Li H, Huang R.
europepmc   +1 more source

In Situ Monitoring of Aptamer-Protein Binding on a ZnO Surface Using Spectroscopic Ellipsometry. [PDF]

Sensors (Basel), 2023
Alshammari A, van Zalinge H, Sandall I.
europepmc   +1 more source